1. March 24, 2020

    PRAC March 2020

    Heard from FAMHP

    Suspension of ulipristal acetate, review of liver injury risk – Testing and treatment recommendations for fluorouracil, capecitabine, tegafur and flucytosine – Review of ifosfamide cancer medicines

    Read more

  2. March 24, 2020

    Coronavirus: European guidelines for the management of clinical trials during the coronavirus pandemic

    Heard from FAMHP

    European guidelines for the management of clinical trials during the coronavirus pandemic are available.

    Read more

  3. March 10, 2020

    ICPM 2020 is postponed

    Considering developing circumstances, IFAPP (the International Federation of
    Associations of Pharmaceutical Physicians and Pharmaceutical Medicine) is postponing
    ICPM2020, March 25-26-27.

    Read more

  4. March 10, 2020

    News of Pharma.be regarding SARS-CoV 2

    The hospital UZ Leuven has informed that they have postponed all non-essential visits by external parties. This also applies to CROs and monitoring visits by pharmaceutical or device companies.

    Read more

  5. March 10, 2020

    NVFG Medical Affairs Dag 2020 CANCELLED

    In the context of COVID-19, the NVFG Medical Affairs Day of 12 March 2020 will be cancelled.

    Read more

  6. January 23, 2020

    Healixia New Year's Event

    On Thursday 23 January 2020, we organised our very first Healixia New Year's Event.

    Read more

  7. January 21, 2020

    President and Vice-president of Healixia elected!

    We are proud to announce that Erik Present (former BeAPP) is the first President of Healixia. Marian Coquel (former BRAS) is our first Vice-president. They are appointed for a period of 2 years.

    Read more

  8. January 21, 2020

    Survey on the use of benzodiazepines and related substances in sleep disorders in Belgium

    Heard from FAMHP

    Bevraging over gebruik van benzodiazepines en aanverwante middelen bij slaapstoornissen in België

    Enquête sur l’utilisation des benzodiazépines et apparentés dans le cadre des troubles du sommeil en Belgique

    Read more

  9. January 21, 2020

    Clamoxyl I.V.-I.M. available again but commercialization scheduled for end 2021

    Heard from FAMHP

    Clamoxyl I.V.-I.M. opnieuw beschikbaar maar stopzetting van commercialisatie voorzien voor eind 2021

    Le Clamoxyl I.V.-I.M. est de nouveau disponible mais l’arrêt de sa commercialisation est prévu pour fin 2021

    Read more

  10. January 21, 2020

    Pilot project on simultaneous national scientific advice starts 1 February 2020

    Heard from FAMHP

    The EU-Innovation Network announces a pilot project for simultaneous national scientific advice (SNSA) to strengthen early regulatory support for innovation. The pilot project kicks off with developing a best practice model starting 1 February 2020.

    Read more